Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Journal of Global Pharma Technology
Ansam W
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Human Herpesvirus-6 in Relapsing Remitting Multiple Sclerosis Ansam W
Journal of Global Pharma Technology Volume 11 Issue 03
Publisher : Journal of Global Pharma Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. HHV-6 has been implicated in the pathology of relapsing Remitting MS. Objective: Study the relation between HHV-6 viremia and relapsing remitting MS. Methods: A case-control study conducted on MS patients. fifty blood samples were collected from relapsing-remitting MS patients-thirty samples from the patients at the time of remission and twenty samples from the patients at the time of relapse and fifty blood samples from apparently healthy controls. Viral DNA extracted from plasma samples, and then, HHV-6 DNA detected and measured by quantitative real-time PCR. Anti HHV-6 IgG and IgM  antibodies measured by ELISA. Results: HHV-6 was detected in 22% (11/50) of MS patients, in 45% (9/20) of relapsing patients and 6.77% (2/30) in remission, while none of the controls was positive for the virus, (P=0.0013) (OR=11.45, P=0.045) (RR=2.9, P= 0.0003). IgG was positive in 48% (24/50) of MS patients and 56% (28/50) of the controls, (P=0.42). While IgM was positive in only 4% (2/50) of MS patients in the relapsing group, (P=0.49).Conclusion: HHV-6 could have a role in the pathology of relapses in MS patients and high viral load might be an indicator of relapse.Keywords: Relapsing-remitting MS, HHV-6, Real time PCR, IgG, IgM. 
Co-Authors